EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solution Paris, France (6 November 2025) – EssilorLuxottica today ...

In a survey of U.S. optometrists, practice owners and managers, about one-third of those not offering myopia management say it is primarily because they lack the expertise to do so, according to a ...

Topline results that were recently released from Sydnexis’s phase 3 Study of Atropine for the Reduction of Myopia Progression ...

SightGlass Vision CEO, Andrew Sedwick, has outlined the origins of technology that helps to limit the progression of myopia ...

An exclusive program uniting the top 12% of U.S. MiSight day prescribers to advance myopia management strategies.

Santen today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ryjunea® (low-dose atropine 0.1 mg/ml), the first licensed treatment in the UK to slow the ...

Surging participation across Myopia Profile’s platforms and partners reflects a worldwide movement to prioritize myopia ...

The US launch of a myopia control spectacle lens, research into modifiable myopia risk factors, and atropine developments ...

EssilorLuxottica announced Essilor Stellest 2.0, the next generation of its myopia management ophthalmic lens ahead of a global rollout in 2026. The lens, which was showcased during the China ...

The team prescribed DIMS lenses to 21 children with myopia (76% girls, mean age: 9.90±1.45 years) and had the children wear the lenses for at least 10 hours per day. Refractive error, axial length (AL ...

Secondary techniques are needed to address macular holes in patients with myopia, according to a speaker at OSN New York ...

A new MyEyeDoctor office is now open at Embrey Mill Town Center, adding to the growing list of businesses locating in one of ...